Bupropion did not improve outcomes when compared to a placebo for female cancer survivors

Results at SABCS show assay has prognostic value that complements value of recurrence score in postmenopausal patients

This study is comparing local consolidative therapy (LCT) and maintenance systemic therapy to maintenance systemic therapy alone for limited-metastatic non-small cell lung cancer

RxPONDER finds postmenopausal women with HR+, HER2- breast cancer with 1-3 involved nodes and an RS of 25 or less can safely skip chemo

Practice-changing trial results find that starting treatment with immunotherapy then giving targeted therapy if the disease progressed led to a significant increase in two-year survival for patients with BRAF V600 mutant metastatic melanoma

Mitchell D. Schnall, MD, PhD was re-elected as the Group Co-Chair, a position he has held since the founding of the ECOG-ACRIN Cancer Research Group in 2012

The National Academy of Medicine announced the election of 90 regular members and 10 international members during its annual meeting this month, including Alliance Group Chair Monica M. Bertagnolli, MD

The addition of short-term androgen suppression to dose escalated radiotherapy (RT) did not improve overall survival compared to dose escalated RT alone

FORTE is a large, randomized trial of surveillance colonoscopy for participants with a first-time diagnosis of 1 or 2 small benign polyps